- Home
- UOKA vs ISPC Comparison
UOKA vs ISPC Comparison
Compare UOKA & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UOKA
- ISPC
- Stock Information
- Founded
- UOKA 2002
- ISPC 2009
- Country
- UOKA United Kingdom
- ISPC United States
- Employees
- UOKA N/A
- ISPC N/A
- Industry
- UOKA
- ISPC Precision Instruments
- Sector
- UOKA
- ISPC Health Care
- Exchange
- UOKA NYSE
- ISPC Nasdaq
- Market Cap
- UOKA 2.7M
- ISPC 3.1M
- IPO Year
- UOKA N/A
- ISPC 2021
- Fundamental
- Price
- UOKA $2.40
- ISPC $0.94
- Analyst Decision
- UOKA
- ISPC
- Analyst Count
- UOKA 0
- ISPC 0
- Target Price
- UOKA N/A
- ISPC N/A
- AVG Volume (30 Days)
- UOKA 128.0K
- ISPC 51.4K
- Earning Date
- UOKA 08-16-2025
- ISPC 08-05-2025
- Dividend Yield
- UOKA N/A
- ISPC N/A
- EPS Growth
- UOKA N/A
- ISPC N/A
- EPS
- UOKA N/A
- ISPC N/A
- Revenue
- UOKA $48,375.00
- ISPC $8,058,631.00
- Revenue This Year
- UOKA N/A
- ISPC $35.93
- Revenue Next Year
- UOKA N/A
- ISPC N/A
- P/E Ratio
- UOKA N/A
- ISPC N/A
- Revenue Growth
- UOKA N/A
- ISPC N/A
- 52 Week Low
- UOKA $1.98
- ISPC $0.86
- 52 Week High
- UOKA $42.50
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- UOKA N/A
- ISPC 37.62
- Support Level
- UOKA N/A
- ISPC $0.86
- Resistance Level
- UOKA N/A
- ISPC $0.97
- Average True Range (ATR)
- UOKA 0.00
- ISPC 0.06
- MACD
- UOKA 0.00
- ISPC -0.02
- Stochastic Oscillator
- UOKA 0.00
- ISPC 18.79
About UOKA MDJM LTD
MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.